CSIMarket
 
China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 
 

China Biologic Products Holdings Inc Growth Comparisons

Select each growth Category to receive further Information



CBPO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 7.9 % 8.35 % 3.53 % 1.72 %
Q / Q Revenue Growth (Q4 MRQ) - 4.91 % 5.24 % 2.89 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 7.9 % 5.1 % 3.74 % %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - 2.18 % 0.62 % 0.2 %
Revenue 5 Year Average Growth 15.67 % 3.46 % 8.17 % 10.53 %


CBPO's Growth Comparisons in IV. Quarter 2019




China Biologic Products Holdings Inc 's Revenue slowed to the 7.9% year on year, improvement in the forth quarter 2019 to 504 millions, underperforming the 8.35% growth in the Biotechnology & Pharmaceuticals industry, but beating the 3.53% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Biotechnology & Pharmaceuticals industry as well, helped to elevate overall market growth to 1.72%.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by 15.67% on average in last five years, while S & P 500's including only Businesses with the forth quarter 2019 earnings reports, average yearly sales growth is 10.53%.


Growth Rates of CBPO's Income in the forth quarter 2019


CBPO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) 11.96 % - - 39.91 %
Seq. Operating Income Change (Q4 MRQ) - 313.6 % -22.97 % 14.77 %
Y / Y Operating Income Growth (Q4 TTM) 11.96 % -38.86 % 227.92 % 5.78 %
Seq. Operating Income Growth (Q4 TTM) 11.96 % 121.13 % 65.5 % 8.43 %
Operating Income 5 Year Avg. Change 8.04 % -10.7 % -1.85 % 12.43 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 10.43 % - 2125.4 % -3.68 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - 1492.83 % 16.54 % -5.05 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 10.43 % -50.1 % 22.13 % -2.84 %
Seq. Income from Cont. Ops. Change (Q4 TTM) 10.43 % - 15.28 % -0.19 %
Income from Cont. Ops. 5 Year Avg. Change 11.2 % -8.98 % 3.1 % 10.64 %

CBPO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 10.43 % - 3588.76 % -5.61 %
Q / Q Net Income Growth (Q4 MRQ) - 1658.63 % 16.27 % -2.82 %
Y / Y Net Income Change (Q4 TTM) 10.43 % -51.43 % 24.42 % -2.78 %
Seq. Net Income Change (Q4 TTM) 10.43 % - 15.06 % -0.72 %
Net Income 5 Year Avg. Growth 11.2 % -8.97 % 3.39 % 11.58 %

CBPO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - - 2125.4 % -3.68 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - 4815.08 % 16.54 % -5.05 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - - - 3.48 %
EPS from Cont. Ops. 5 Year Avg. Growth - -34.3 % 3.1 % 10.64 %



CBPO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - - 3588.76 % -5.61 %
Q / Q EPS Net Growth (Q4 MRQ) - 5326.68 % 16.27 % -2.82 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -30.63 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) - - - -28.67 %
EPS Net 5 Year Avg. Change - -8.97 % 3.39 % 11.58 %



China Biologic Products Holdings Inc reported bottom-line of $ 0.00 in the forth quarter, compare to $ 3.53 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry grew by 8.35%, while Healthcare sector increased by 3588.76%, and overall market declined by -5.61%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by 15.67% on average in the last five years, while the S & P 500's including only the businesses with the forth quarter 2019 financial results, average yearly income per share growth is 11.58%.

CBPO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) 120.64 % 66.28 % 18.26 % 52.98 %
Seq. Free Cash Flow Change (Q4 MRQ) - 10.61 % -0.31 % 54.2 %
Y / Y Free Cash Flow Change (Q4 TTM) 120.64 % 14.76 % 8.25 % -1.47 %
Seq. Free Cash Flow Change (Q4 TTM) 120.64 % 5.17 % 10.88 % 12.96 %
Free Cash Flow 5 Year Avg. Change 23.33 % -2.72 % 5.74 % 14.32 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 3808.2 % 1088.9 % -
Seq. Net Cash Flow Change (Q4 MRQ) - 138.05 % 5.23 % -11.41 %
Y / Y Net Cash Flow Change (Q4 TTM) - 221.8 % 72.27 % -
Seq. Net Cash Flow Change (Q4 TTM) - 528.89 % 151.93 % -
Net Cash Flow 5 Year Avg. Change - - 66.57 % 329.82 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -33.85 % -68.96 % -21.07 % -2.41 %
Seq. Capital Expenditures Change (Q4 MRQ) - 54.05 % 7.75 % 15.42 %
Y / Y Capital Expenditures Change (Q4 TTM) -33.85 % -20.43 % 4.49 % -1.82 %
Seq. Capital Expenditures Change (Q4 TTM) -33.85 % -37.36 % -6.08 % -0.36 %
Capital Expenditures 5 Year Avg. Change -